Intranasal Drug Delivery Markets, 2024: Allergic Infections, Analgesics, Osteoporosis & Vaccinations - Global Strategic Business Report 2018 - ResearchAndMarkets.com

DUBLIN--()--The "Intranasal Drug Delivery - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.

Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for this market. Market data and analytics are derived from primary and secondary research.

This report analyzes the US Market for Intranasal Drug Delivery in US$ Million by the following Therapeutic Areas:

  • Allergic Infections
  • Analgesics
  • Osteoporosis
  • Vaccinations

The report profiles 64 companies including many key and niche players such as:

  • Aegis Therapeutics LLC (USA)
  • AptarGroup, Inc. (USA)
  • AstraZeneca Plc. (UK)
  • MedImmune, Inc. (USA)
  • Becton Dickinson and Company (USA)
  • GlaxoSmithKline Plc. (UK)
  • Johnson & Johnson Inc. (USA)
  • Marina Biotech, Inc. (USA)
  • Merck & Co., Inc. (USA)
  • Nemera (France)
  • Novartis AG (Switzerland)
  • OptiNose US Inc. (USA)
  • Pfizer, Inc. (USA)
  • Valeant Pharmaceuticals International, Inc. (Canada)

Key Topics Covered:

1. Industry Overview

2. Market Drivers, Trends & Issues

3. Recent Research & Development Initiatives

4. Technology Overview

5. Nasal Delivered Drugs: An Overview

6. Product Developments, Approvals & Introductions

7. Recent Industry Activity

8. Focus On Select Players

9. US Market Analytics

Total Companies Profiled: 64 (including Divisions/Subsidiaries 81)

  • The United States (48)
  • Canada (4)
  • Japan (2)
  • Europe (17)
    • France (2)
    • Germany (4)
    • The United Kingdom (4)
    • Rest of Europe (7)
  • Asia-Pacific (Excluding Japan) (7)
  • Middle East (2)
  • Latin America (1)

For more information about this report visit https://www.researchandmarkets.com/research/g5f2zz/intranasal_drug?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Transdermal and Transmucosal Drug Delivery

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Transdermal and Transmucosal Drug Delivery